Vincent Serra
Directeur des opérations chez NEOVACS
Postes actifs de Vincent Serra
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEOVACS | Directeur Technique/Scientifique/R&D | - | - |
| Directeur des opérations | - | - | |
| Directeur Général | - | - | |
| BioSupport AG | Corporate Officer/Principal | - | - |
Historique de carrière de Vincent Serra
Anciens postes connus de Vincent Serra
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Directeur Général | 01/08/2005 | 01/02/2014 |
| Directeur Technique/Scientifique/R&D | 01/08/2005 | 01/02/2014 | |
| Fondateur | 22/12/2009 | 01/02/2014 | |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Corporate Officer/Principal | 03/01/1999 | 01/02/2005 |
| ABIVAX | Corporate Officer/Principal | - | - |
Formation de Vincent Serra
| University of Grenoble | Doctorate Degree |
Statistiques
Internationale
| France | 4 |
| Etats-Unis | 2 |
| 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEOVACS | Health Technology |
| ABIVAX | Health Technology |
| Entreprise privées | 3 |
|---|---|
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The private company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Health Technology |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
| BioSupport AG |
- Bourse
- Insiders
- Vincent Serra
- Expérience
